Chronic Myeloproliferative Disorders Completed Phase Trials for Busulfan (DB01008)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00296023Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerTreatment
NCT00513474Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantSupportive Care